Cargando…
GATA2 as a potential metastasis-driving gene in prostate cancer
Effective treatment for metastatic prostate cancer is critically needed. The present study was aimed at identifying metastasis-driving genes as potential targets for therapy (oncotargets). A differential gene expression profile of metastatic LTL-313H and non-metastatic LTL-313B prostate cancer tissu...
Autores principales: | Chiang, Yan Ting, Wang, Kendric, Fazli, Ladan, Qi, Robert Z., Gleave, Martin E., Collins, Colin C., Gout, Peter W., Wang, Yuzhuo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3964220/ https://www.ncbi.nlm.nih.gov/pubmed/24448395 |
Ejemplares similares
-
Prostate cancer metastasis-driving genes: hurdles and potential approaches in their identification
por: Chiang, Yan Ting, et al.
Publicado: (2014) -
Identification of DEK as a potential therapeutic target for neuroendocrine prostate cancer
por: Lin, Dong, et al.
Publicado: (2014) -
The BIRC6 gene as a novel target for therapy of prostate cancer: dual targeting of inhibitors of apoptosis
por: Iris Luk, Sze Ue, et al.
Publicado: (2014) -
BIRC6 Protein, an Inhibitor of Apoptosis: Role in Survival of Human Prostate Cancer Cells
por: Low, Christopher G., et al.
Publicado: (2013) -
A noncanonical AR addiction drives enzalutamide resistance in prostate cancer
por: He, Yundong, et al.
Publicado: (2021)